| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.177 | 6.361 | 2.859 | 757 | 4.153 | 2.653 | 2.936 | 9.995 | 3.764 | 5.834 |
| Total Income - EUR | 4.177 | 6.361 | 2.859 | 757 | 4.153 | 2.653 | 2.936 | 9.995 | 3.764 | 5.834 |
| Total Expenses - EUR | 9.642 | 9.585 | 9.125 | 8.519 | 10.515 | 8.767 | 10.189 | 12.962 | 10.866 | 12.429 |
| Gross Profit/Loss - EUR | -5.465 | -3.225 | -6.267 | -7.762 | -6.362 | -6.115 | -7.253 | -2.968 | -7.102 | -6.596 |
| Net Profit/Loss - EUR | -5.590 | -3.388 | -6.295 | -7.769 | -6.401 | -6.141 | -7.282 | -3.068 | -7.140 | -6.596 |
| Employees | 0 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Ulicrisalin S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.560 | 18.740 | 17.910 | 17.078 | 16.277 | 15.540 | 14.811 | 13.184 | 24.615 | 23.915 |
| Current Assets | 4.679 | 5.421 | 7.331 | 8.364 | 5.517 | 4.180 | 3.674 | 547 | 467 | 1.265 |
| Inventories | 2.409 | 2.977 | 5.022 | 5.807 | 3.331 | 2.719 | 2.659 | 117 | 142 | 254 |
| Receivables | 2.224 | 2.271 | 2.303 | 2.500 | 2.166 | 1.457 | 989 | 242 | 52 | 0 |
| Cash | 46 | 174 | 6 | 57 | 20 | 4 | 26 | 188 | 274 | 1.011 |
| Shareholders Funds | -14.155 | -17.399 | -23.399 | -30.739 | -36.545 | -41.994 | -48.344 | -51.562 | -46.264 | -52.601 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 37.394 | 41.560 | 48.640 | 56.181 | 58.339 | 61.713 | 66.829 | 65.293 | 71.345 | 77.781 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4520 - 4520" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Ulicrisalin S.r.l.